relcovaptan has been researched along with Obesity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthus, MF; Bankir, L; Bichet, DG; Bouby, N; Chollet, C; Desposito, D; Enhorning, S; Foufelle, F; Hainault, I; Magnan, C; Melander, O; Paradis, V; Philippe, E; Roussel, R; Taveau, C; Velho, G; Waeckel, L | 1 |
1 other study(ies) available for relcovaptan and Obesity
| Article | Year |
|---|---|
Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Blood Glucose; Drinking; Fatty Liver; Glucose Intolerance; Glucose Tolerance Test; Indoles; Male; Obesity; Pyrrolidines; Rats, Zucker; Vasopressins | 2015 |